Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open‐Label Study

Documenti analoghi

• Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
  di: Bridget L. Morse, et al.
  Pubblicazione: (2025)
• A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole
  di: Olivia Campagne, et al.
  Pubblicazione: (2024)
• Two Phase I, Randomized, Open‐Label, Multiple‐Dose, Crossover Studies Investigating the Systemic Bioavailability of Topical Diclofenac Diethylamine Gels Compared With Oral Diclofenac Tablets
  di: Grit Andersen, et al.
  Pubblicazione: (2025)
• Identification of a Safe and Tolerable Carbamazepine Dosing Paradigm that Facilitates Effective Evaluation of CYP3A4 Induction
  di: Amita Datta‐Mannan, et al.
  Pubblicazione: (2024)
• A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants
  di: Yohannes Teffera, et al.
  Pubblicazione: (2025)